Table 6 Relative risk for site of first recurrence by breast cancer subtype in 300 women
From: Factors that predict recurrence later than 5 years after initial treatment in operable breast cancer
Site | TNBC (n = 57) | HER2 (n = 37) | ER/PR/HER2 (n = 28) | ER/PR (n = 178) | ||||
|---|---|---|---|---|---|---|---|---|
RR/CI | p | RR/CI | p | RR/CI | p | RR/CI | p | |
Lung | 0.959/0.49–1.84 | 0.901 | 0.655/0.36–1.19 | 0.166 | 0.495/0.22–1.11 | 0.083 | 1.399/0.82–2.35 | 0.207 |
Bone | 0.554/0.30–1.00 | 0.052 | 0.708/0.40–0.23 | 0.223 | 1.159/0.53–2.52 | 0.710 | 1.849/1.15–2.95 | 0.010 |
Brain | 2.493/1.04–5.92 | 0.034 | 2.489/1.07–5.78 | 0.030 | 3.436/1.25–9.44 | 0.024 | 0.222/0.09–0.54 | <0.001 |
Liver | 1.439/0.76–2.70 | 0.256 | 4.897/2.71–8.82 | <0.001 | 1.70/0.74–3.86 | 0.201 | 0.220/0.12–0.38 | <0.001 |
LN | 1.641/0.85–3.13 | 0.131 | 2.160/1.17–3.96 | 0.012 | 1.748/0.75–4.06 | 0.191 | 0.397/0.22–0.69 | 0.001 |
Skin | 1.112/0.53–2.32 | 0.777 | 0.577/0.25–1.29 | 0.177 | 0.740/0.24–2.22 | 0.551 | 1.327/0.71–2.45 | 0.365 |